The Effect of Hydroxyzine on Akathisia and Other Neurological Side Effects of Antipsychotics in the Treatment of Paranoid Schizophrenia

DOI: 10.47026/2413-4864-2023-3-42-49

UDC: 615.214.2:615.065:616.895.87
BBC: 56.145.51+52.817.105+53.527

Semenikhin D.G., Burashnikova I.S., Karpov A.M., Bashmakova O.V.

The Effect of Hydroxyzine on Akathisia and Other Neurological Side Effects of Antipsychotics in the Treatment of Paranoid Schizophrenia

Keywords: Hydroxyzine, antipsychotics, tranquilizers, neurological side effects, extrapyramidal disorders, akathisia, correction

Side effects of antipsychotic drugs are the most urgent problem in the pharmacotherapy of schizophrenia. Medications used to correct side effects of various pharmacological groups, including correctors of cholinolytics, tranquilizers-benzodiazepines, have severe side effects, which justifies the search for no less effective and at the same time safer alternatives. The aim of the study was to evaluate the corrective effect of Hydroxyzine on akathisia and other neurological disorders that develop as side effects of antipsychotic therapy. Materials and methods. The study analyzed the severity of side effects in 43 patients suffering from paranoid schizophrenia receiving monotherapy with antipsychotics, before their administration, on the 7^th and 21^st day after the start of taking Hydroxyzine. The severity of side effects was assessed by the ESRS scales and the scale of evaluating drug-induced akathisia. Results. A significant corrective effect of Hydroxyzine on akathisia and other neurological side effects of antipsychotics was shown on the 7^th day of Hydroxyzine therapy, the severity of Parkinsonism, dyskinesia, akathisia and tremor significantly decreased. Patients noted an improvement in general well-being, a decrease in the level of anxiety associated with the disease, staying in a psychiatric hospital, side effects of psychopharmacotherapy. Hydroxyzine significantly reduced the severity of akathisia, assessed both objectively and subjectively by patients. There was a decrease in the need of patients to move, to change the position of the body, improved sleep, reduced emotional stress. In general, Hydroxyzine had a positive effect in the form of a decrease in pathological motor activity and a decrease in the severity of emotional manifestations associated with the side effect of antipsychotics, which persisted on the 21^st day of Hydroxyzine therapy in the absence of clinically significant undesirable side effects. Conclusions. The results of the study show the effectiveness of Hydroxyzine for correcting neurological side effects of antipsychotics along with good tolerability and substantiate the possibility of expanding its use in the complex therapy of paranoid schizophrenia.

References

Aivozen S.A., Enyukov I.S., Meshalkin L.D. Osnovy modelirovaniya i pervichnaya obrabotka dannykh [Fundamentals of modeling and primary data processing]. Moscow, Finansy i statistika Publ., 1983, 440 p.
Bashmakova O.V., Semenikhin D.G., Karpov A.M. Biopsikhosotsial’nye aspekty professional’noi deyatel’nosti vrachei-psikhiatrov [Biopsychosocial aspects of the professional activity of psychiatrists]. Kazan, Meddok Publ., 2012, 136 p.
Bekker R.A., Bykov Yu.V. Sovremennye vozmozhnosti korrektsii pobochnykh effektov antidepressantov i antipsikhotikov [Modern possibilities for correcting the side effects of antidepressants and antipsychotics]. Psikhiatriya i psikhofarmakoterapiya, 2020, vol. 22, 4, pp. 14–20.
Burashnikova I.S. Kliniko-farmakologicheskie podkhody k optimizatsii primeneniya antipsikhotikov v psikhiatricheskom statsionare (farmakoekonomika, farmakoepidemiologiya, monitoring pobochnykh reaktsii, farmakogenetika): dis…. kand.med. nauk [Clinical and pharmacological approaches to optimizing the use of antipsychotics in a psychiatric hospital (pharmacoeconomics, pharmacoepidemiology, monitoring of adverse reactions, pharmacogenetics). Cand. Diss.]. Moscow, 2018, 137 p.
Burashnikova I.S., Minnekeeva K.A., Semenikhin D.G. Otsenka rezul’tatov ispol’zovaniya atipichnykh neiroleptikov v psikhiatricheskom statsionare Respubliki Tatarstan v 2008–2012 gg.: bezopasnost’ i vliyanie na byudzhet [Evaluating the results of use of atypical antipsychotics in psychiatric hospital in the Republic of Tatarstan in 2008–2012: safety and budget burden]. Vestnik Roszdravnadzora, 2015, no. 1, pp. 61–65.
Burashnikova I.S., Semenikhin D.G. Analiz potrebleniya lekarstvennykh sredstv-korrektorov pobochnykh effektov neirolepticheskoi terapii [Analysis of the consumption of medicines-correctors of the side effects of neuroleptic therapy]. In: Aktual’nye voprosy eksperimental’noi i klinicheskoi meditsiny: sb. materialov nauch.-prakt. konf. molodykh uchenykh s mezhdunarodnym uchastiem [Topical issues of experimental and clinical medicine: collected papers]. Cheboksary, Chuvash State University Publ., 2014, pp. 37–39.
Semenikhin D.G., Maksimov M.L., Karpov A.M. et al. Vliyanie bromdigidrokhlorfenilbenzodiazepina na ekstrapiramidnye narusheniya, voznikshie pri antipsikhoticheskoi terapii paranoidnoi shizofrenii [Influence of bromdihydrochlorophenylbenzodiazepine on extrapyramidal disorders that arose during antipsychotic therapy of paranoid schizophrenia]. Farmateka, 2017, no. 20(353), pp. 57–60.
Bobrov A.E., Kulygina M.A., Belyanchikova M.A. et al. Vliyanie preparata Ataraks na kognitivnye funktsii pri lechenii trevozhnykh rasstroistv [Influence of Atarax on cognitive functions in the treatment of anxiety disorders]. Nervnye bolezni, 2005, no. 3, pp. 30–34.
Zhilenkov O.V. O korrelyatsii neirolepticheskikh depressii i akatizii [On the correlation of neuroleptic depression and akathisia]. In: Petryuk P.T., Bacherikov A.N., eds. Aktual’nye voprosy sovremennoi psikhiatrii i narkologii: Sbornik nauchnykh rabot Instituta nevrologii, psikhiatrii i narkologii AMN Ukrainy i Khar’kovskoi oblastnoi klinicheskoi psikhiatricheskoi bol’nitsy № 3 (Saburovoi dachi), posvyashchennyi 210-letiyu Saburovoi dachi [Topical issues of modern psychiatry and narcology: Collection of scientific papers of the Institute of Neurology, Psychiatry and Narcology of the Academy of Medical Sciences of Ukraine and the Kharkiv Regional Clinical Psychiatric Hospital No. 3 (Saburova dacha), dedicated to the 210^th anniversary of Saburova dacha]. Kiev, Kharkiv, 2010, vol. 5. Available at: http://www.psychiatry.ua/books/actual/paper036.htm.
Kuznetsova A.L. Korrektsiya afobazolom pobochnykh effektov galoperidola i triftazina i poisk novykh neiroleptikov v ryadu Pro-Tyr-soderzhashchikh tetrapeptidov: dis. … kand. biol. nauk. [Correction of the side effects of haloperidol and triftazine with afobazole and the search for new antipsychotics in the series of Pro-Tyr-containing tetrapeptides: Cand. Diss.]. Moscow, 2011, 137 p.
Lyubov E.B. Sotsial’no-ekonomicheskoe bremya shizofrenii [Socio-economic burden of schizophrenia]. Sotsial’naya i klinicheskaya psikhiatriya, 2012, vol. 12, no. 3, pp. 100–108.
Malin D.I. Pobochnoe deistvie psikhotropnykh sredstv [Side effects of psychotropic drugs]. Moscow, Vuzovskaya kniga Publ., 2000, 207 p.
Malin D.I., Kozyrev V.V., Ravilov R.S. Ekstrapiramidnye pobochnye effekty neiroleptikov: klassifikatsiya i sovremennye sposoby korrektsii [Extrapyramidal side effects of neuroleptics: classification and modern methods of correction]. Psikhiatriya i psikhofarmakoterapiya, 2001,vol. 3, no. 8, pp. 31–35.
Rebrova O.Yu. Statisticheskii analiz meditsinskikh dannykh. Primenenie prikladnykh programm Statistica [Statistical analysis of medical data. Application of application programs Statistica]. Moscow, Mediasfera Publ., 2002, 312 p.
Ryabokon’ I.V. Ataraks pri trevozhnykh rasstroistvakh (obzor) [Atarax in anxiety disorders (review)]. Russkii Medicinskii Zhurnal, 2011, no. 15, p. 984.
Semenikhin D.G. Osobennosti primeneniya mebikara v kompleksnoi terapii nekotorykh psikhicheskikh zabolevanii: avtoref. dis.… kand. med. nauk [Peculiarities of the use of mebicar in the complex therapy of certain mental illnesses: Abstract of Doct. Diss.]. Kazan, 1991, 22 p.
Semenikhin D.G. Proyavleniya pobochnykh effektov neirolepticheskoi terapii pri pervoi i posleduyushchikh gospitalizatsiyakh u bol’nykh paranoidnoi shizofreniei [Manifestations of side effects of neuroleptic therapy during the first and subsequent hospitalizations in patients with paranoid schizophrenia]. Psikhicheskoe zdorov’e, 2009,vol. 7, no. 12(43), pp. 30–32.
Spivak L.I., Raiskii V.A., Vilenskii B.S. Oslozhneniya psikhofarmakologicheskoi terapii [Complications of psychopharmacological therapy]. Leningrad, Meditsina Publ., 1988, 168 p.
Chernetsov N.Yu. Sravnitel’naya effektivnost’ terapii trevozhno-depressivnykh rasstroistv sovremennymi antidepressantami i atipichnym trankvilizatorom gidroksizinom u patsientov psikhoterapevticheskogo kabineta gorodskoi polikliniki [Comparative efficacy of treatment of anxiety-depressive disorders with modern antidepressants and the atypical tranquilizer hydroxyzine in patients of the psychotherapeutic office of a city polyclinic]. In:Materialy XIV s’ezda psikhiatrov Rossii (15–18 noyabrya 2005 g.) [Proc. of the 14^thCongress of Psychiatrists of Russia (2005, Nov. 15–18)]. Moscow, Medpraktika-M Publ.,2005, pp. 203–204.
Janicak P.G., Davis J.M. et al. Principles and practice of psychopharmacotherapy. LWW, 1993. (Russ. ed.: Printsipy i praktika psikhofarmakoterapii. Kiev, Nika-Tsentr Publ., 1999, 694 p.).
Barnes T.R. A rating scale for drug-induced akathisia. British Journal of Psychiatry, 1989, vol. 154, pp. 672–676.
Chouinard G., Ross-Chouinard A., Annable L., Jones B.D. The Extrapyramidal Symptoms Rating Scale. Can J Neurol Sci., 1980, vol. 7(3), pp. 233–244.
Fleischhacker W.W., Roth S.D., Kane J.M. The pharmacologic treatment of neuroleptic-induced akathisia. Journal of Clinical Psychopharmacology, 1990, vol. 10(1), pp. 12–21. DOI: https://doi.org/10.1097/00004714-199002000-00003.
Krebs M.O. Le trouble anxieux: clinique et implicacion neurobiologiques. La Revfue des Entretiens de Bichat, 2001, vol. 2 (5).
Morrison P., Meehan T., Stomski N.J. Living with antipsychotic medication side-effects: the experience of Australian mental health consumers. Int J Ment Health Nurs., 2015, vol. 24(3), pp. 253–261. DOI: 10.1111/inm.12110. Epub 2014 Dec 22. PMID: 25529392.

About authors

Semenikhin Dmitry G.: Candidate of Medical Sciences, Associate Professor, Department of Clinical Pharmacology and Pharmacotherapy, Kazan State Medical Academy – Branch Campus of the Russian Medical Academy of Continuous Professional Education, Russia, Kazan (sdg1957@mail.ru; )

Burashnikova Irina S.: Candidate of Medical Sciences, Associate Professor, Department of Clinical Pharmacology and Pharmacotherapy, Kazan State Medical Academy – Branch Campus of the Russian Medical Academy of Continuous Professional Education, Russia, Kazan (irinabis25@mail.ru; ORCID: https://orcid.org/0000-0002-8511-5696)

Karpov Anatoly M.: Doctor of Medical Sciences, Professor, Head of the Department of Psychotherapy and Narcology, Kazan State Medical Academy – Branch Campus of the Russian Medical Academy of Continuous Professional Education, Russia, Kazan (kam1950@mail.ru; ORCID: https://orcid.org/0000-0001-9777-5571)

Bashmakova Olga V.: Candidate of Medical Sciences, Associate Professor, Department of Psychotherapy and Narcology, Kazan State Medical Academy – Branch Campus of the Russian Medical Academy of Continuous Professional Education, Russia, Kazan (olga_bash@rambler.ru; )

Article link

Semenikhin D.G., Burashnikova I.S., Karpov A.M., Bashmakova O.V. The Effect of Hydroxyzine on Akathisia and Other Neurological Side Effects of Antipsychotics in the Treatment of Paranoid Schizophrenia [Electronic resource] // Acta medica Eurasica. – 2023. – №3. P. 42-49. – URL: https://acta-medica-eurasica.ru/en/single/2023/3/5/. DOI: 10.47026/2413-4864-2023-3-42-49.

Single article

Semenikhin D.G., Burashnikova I.S., Karpov A.M., Bashmakova O.V.